BACKGROUND: Long-term exposure to particulate matter <2.5 µm in diameter (PM 2.5 ) and ozone has been associated with the development and progression of cardiovascular disease and, in the case of PM 2.5 , higher cardiovascular mortality. Whether exposure to PM 2.5 and ozone is associated with patients' health status and quality of life is unknown. We used data from 2 prospective myocardial infarction (MI) registries to assess the relationship between long-term PM 2.5 and ozone exposure with health status outcomes 1 year after an MI.
xposure to air pollutants is an important risk factor for premature morbidity and mortality. 1 Fine particulate matter <2.5 µm in diameter (PM 2.5 ) and ozone are the most studied air pollutants and have been associated with a wide range of diseases. 1 Longterm exposure to PM 2.5 has been implicated in the development and progression of cardiovascular disease. [2] [3] [4] [5] Complex and interlinked mechanisms have been proposed to explain this association with PM 2.5 exposure, including higher rates of atherosclerosis 6, 7 and the development of cardiometabolic conditions, such as diabetes mellitus (DM), hypertension, and dyslipidemia. 8 In contrast to PM 2.5 , there is some uncertainty between ozone exposure and cardiovascular outcomes. In a large study of over 400 000 participants, investigators did not find an association between ozone levels and cardiovascular mortality independent of PM 2.5 . 9 Other studies have found an association between ozone exposure and mortality because of embolism, 10 ischemic heart disease, 11 heart failure, 12 and stroke, 13 but not all of these studies evaluated this association with ozone independent of PM 2.5 .
Beyond mortality, patients are equally or more concerned about their health status: their symptoms, function, and quality of life (QoL). To date, there have been no studies examining the association between exposure to PM 2.5 and ozone with patients' health status among patients with coronary artery disease (CAD). A deeper understanding of the potential impact of air pollution may further guide public policy about air quality standards, as the health benefits of stricter standards are better understood. Accordingly, we used data from the 2 prospective myocardial infarction (MI) registries to assess the relationship between long-term exposure to these important air pollutants with health status 1 year after MI.
METHODS
The investigators are willing to work with others who are interested in validating or extending the analyses. Air quality data for the United States is publically available. The analytical codes can be made available but patient-specific data will not be publically available.
Study Population
For this study, we included data on patients with an acute MI from 2 prospective registries with detailed information on patients' disease-specific health status. The TRIUMPH (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction) and PREMIER (Prospective Registry Evaluating Myocardial Infarction: Events and Recovery) studies enrolled patients form 31 US hospitals between 2003 and 2008. Detailed design and methods for these registries have previously been described. 14, 15 Briefly, patients were required to have biomarker evidence of myocardial necrosis and additional clinical evidence supporting the diagnosis of MI, including prolonged ischemic signs/symptoms or electrocardiographic criteria of ST-segment changes. Baseline data were obtained through chart abstraction and structured interviews by trained research coordinators. Health status data were obtained at baseline and during follow-up, including 1 year after the patients' MI, using standardized interview conducted by trained study personnel. Each participating site obtained Institutional Research Board approval, and all patients provided written informed consent for the interview.
Assessment of Air Pollution Exposures
Each patient's exposure to ambient air PM 2.5 and ozone was estimated using publicly available data from Community Multi-Scale Air Quality Model and point measurements provided by the United States Environment Protection Agency (EPA). 16 For this study, exposure to PM 2.5 was based on average daily concentrations, expressed in microgram per cubic meter (µg/m 3 ). Exposure to ozone was based on the average of daily 8-hour maximum ozone levels, expressed in parts per million (ppm) moist air molecules in a fixed air volume. These metrics to assess long-term exposure are used commonly throughout the world, and the EPA reports PM 2.5 and ozone exposure using these metrics. 16, 17 Daily average PM 2.5 and 8-hour maximum ozone levels were derived from a Bayesian space-time downscaling fusion model by estimating concentrations at the census tract centroid of the patient's residence on the basis of National Air Monitoring Stations/State and Local Air Monitoring Stations and Community Multi-Scale Air Quality Model model data in 12×12 km grids. Downscaler PM 2.5 and ozone estimates
WHAT IS KNOWN
• Long-term exposure to ambient air particulate matter <2.5 µg and ozone has been associated with development and progression of coronary artery disease and, in the case of particulate matter <2.5 µg, higher long-term mortality risk after an acute myocardial infarction.
WHAT THE STUDY ADDS
• In patients with coronary artery disease 1 year after a myocardial infarction, we found higher exposure to both particulate matter <2.5 µg and ozone to be modestly but independently associated with poorer generic and disease-specific health status.
• These associations were not attenuated after adjusting for demographics, socioeconomic status, and prevalence of comorbidities.
• The associations were also preserved after adjusting for baseline health status, indicating that poor air quality was also associated with recovery of health status following a myocardial infarction.
• Similar to previous studies, higher exposure to particulate matter <2.5 µg was associated with higher risk of mortality over 5 years after myocardial infarction.
consider all monitors, as opposed to the most prevalent monitor, in areas where there are multiple monitors per site. 18 The downscaling model performance using the predictive mean absolute error showed that the model outperformed ordinary kriging or Community Multi-Scale Air Quality Model models. 19 The main focus of our article was to examine an association of exposure to air pollutants with health status. However, we also wanted to assess if previously described association of greater exposure to air pollutants with mortality was similar in our study cohort. Different approaches for the measurement of air pollutant exposure were used for the health status and mortality comparisons. Because the health status comparison was 1 year after the MI, we used average pollutant exposure over the year after a patient's MI. In contrast, as the mortality analyses examined survival after discharge, the air pollution exposure over the year before the MI was used.
Study Outcomes
Our main study outcome was health status at 1 year after MI. Disease-specific health status was assessed using the Seattle Angina Questionnaire (SAQ). The SAQ is a valid 19-item instrument with a 4-week recall period. It measures 5 domains of health in patients with CAD, which are angina frequency, angina stability, QoL (SAQ QoL), physical limitation, and treatment satisfaction. 20 Domain scores range from 0 to 100, with higher scores indicating fewer symptoms and better QoL. The primary outcome for this study was the overall health status, which is summarized using the SAQ summary score and reflects the average of the SAQ physical limitation, angina frequency, and QoL domains. 21 In addition, we assessed the effect of air pollutants on other health status measures. These included physical health status, as measured by the Physical Component Summary of the Medical Outcomes Study 12-item Short Form (SF-12 PCS). 22 The SF-12 is a reliable and valid measure of generic health status and provides summary component scales for overall physical and mental health. 23 As dyspnea is a common angina equivalent in patients with CAD 24 and might also be associated with higher air pollution levels, we also assessed the effect of air pollutants on dyspnea using a 4-level dyspnea item based on the Rose Dyspnea Scale. The Rose Dyspnea Scale is a 4-item questionnaire with a 1-month recall period that assesses the patient's level of dyspnea with common activities. 25 Each activity associated with dyspnea is assigned 1 point, with scores of 0 indicating no dyspnea and increasing scores indicating greater limitation from dyspnea. The Rose Dyspnea Scale has been used to assess symptoms in patients with CAD and has shown to be associated with QoL, rehospitalization, procedure success, and long-term outcomes. 26 Last, mortality status over 5 years was determined through a query of the Centers for Disease Control's National Death Index.
Statistical Analysis
Baseline demographic and clinical characteristics of patients were compared across quartiles of average PM 2.5 exposure. Differences in patient characteristics across quartiles of exposure were compared using ANOVA for continuous variables and χ 2 tests for categorical variables. Categorical variables are presented as mean±SD or median with interquartile range.
Categorical variables are presented as number (n) with a percentage.
We evaluate the association between exposures to average daily ambient air PM 2.5 and ozone with health status using generalized additive models with gaussian errors for SAQ and SF-12 PCS scores and using a proportional odds logistic regression model for dyspnea scores. Smoothing or restricted cubic splines were used to allow for nonlinear associations. Several models were defined a priori. In Model 1, we assessed unadjusted associations with PM 2.5 and ozone without adjusting for any covariates, except for ozone levels when assessing PM 2.5 and adjusting for PM 2.5 when assessing the impact of ozone. In Model 2, we additionally adjusted for covariates known to be associated with health status in patients with CAD. 27 These were demographics (age, sex, and race), smoking, date of enrollment, and socioeconomic status (SES). SES has been shown to be associated with worse outcomes after MI 28 and was quantified using patients' education, insurance status, history of avoiding care because of costs, and end-of-the-month financial resources. We also adjusted for date of enrollment to account for temporal or seasonal effects. Because PM 2.5 has been previously shown to be associated with the development of hypertension, DM, chronic kidney disease (CKD; defined as estimated glomerular filtration rate <60), and heart failure, 8 we constructed Model 3 to assess whether there remained an independent association between exposure to PM 2.5 and ozone and health status after accounting for these factors; which could potentially have either confounding or mediating effects or both. Next, to evaluate whether air pollutants were also associated with change in health status following MI we constructed an additional model using change in health status from baseline to 1 year as the outcome with adjustment for the covariates included in the second model, as well as baseline health status. Finally as higher concentrations of ozone can amplify the adverse cardiovascular effects of PM 2.5 , 29 we augmented Model 2 to include an interaction between PM 2.5 and ozone levels and estimated the effect of PM 2.5 at different ozone concentrations (10th and 90th percentiles and median of the distribution in our study).
While the main objective of our article was to determine the association of air pollutant exposure with the health status of patients with stable ischemic heart disease who recently had an MI, we also wanted to see if the association of PM 2.5 with mortality was similar in our study cohort as has been described in previous studies. Hence, we examined the association of 12-month average air quality parameters before patient's MI with all-cause mortality through 5 years after patients' index MI. We calculated crude survival rates by quartiles of PM 2.5 and ozone exposure using Kaplan-Meier methods, and we estimated hazard ratios using Cox regression models adjusted for patients' demographics (age, sex, and race), SES, smoking status, and comorbidities, including hypertension, DM, CKD, heart failure, left ventricular function, before MI, and Global Registry of Acute Coronary Events mortality risk score. We additionally adjusted for ozone levels when assessing the associations between PM 2.5 and outcomes and PM 2.5 levels when assessing association with ozone. The proportional hazards assumptions were assessed using Schoenfeld residuals.
All models included smoothing or restricted cubic splines for estimating effects of continuous variables to accommodate nonlinear relationships. In cases where no significant evidence of nonlinearity was found, associations were reestimated using linear effects to simplify interpretation. All analyses were performed using SAS version 9.4 (SAS Institute Inc, Cary, NC) and R version 3.5.2.
30 P values were evaluated at a 2-sided significance level of 0.05.
RESULTS

Study Population
The PREMIER and TRIUMPH studies enrolled a total of 2498 (between January Tables I and II in the Data Supplement compare the differences in patient characteristics between patients who were excluded and those who were not. There were significant differences in age, race, SES, and burden of comorbidities. Patients who were excluded were younger had worse SES across all 4 SES variables that were assessed and a higher proportion had hypertension, DM, CKD, and heart failure. We adjusted for all these factors in our outcome analysis. Additionally, patients who were excluded had on average lower peak troponin levels, lower Global Registry of Acute Coronary Events mortality scores, and a lower proportion presented with ST-segment-elevation MI.
The mean age of the final analytical cohort was 60.6±12.2, 33% were females and 25% were nonwhite. Comorbidities were common, with 64% of the patients having hypertension, 28% having DM, and 40% having systolic dysfunction (ejection fraction <50%). Fifteen percent of the patients were uninsured and 16% reported not having enough money at the end of the month to make ends meet. The mean 12-month average PM 2.5 and ozone exposure per patient were 11.96±2.11 µg/m 3 (range =4.3-20.5) and 0.0383±0.0035 ppm (range= 0.0267-0.0534). There was no significant correlation between average PM 2.5 exposure and average ozone exposure (Spearman r =−0.02, P=0.15). Table 1 describes the baseline demographic and clinical characteristics, stratified according to quartiles of PM 2.5 concentration. Patients in higher quartiles of PM 2.5 concentration had lower Global Registry of Acute Coronary Events scores, lower peak troponin level, were more likely to avoid care due to costs, and were more likely to have hypertension, prior MI, DM, heart failure, CKD, and chronic lung disease. Table III in the Data Supplement describes the baseline demographics and clinical characteristics of patients stratified according to quartiles of ozone exposure. There were significant differences in the prevalence of DM, heart failure, and CKD in groups stratified by ozone exposure.
Association Between PM 2.5 and Ozone With Health Status
The mean SAQ summary score at 1 year was 89.2±15.7. The mean dyspnea score was 0.80±1.08, and the mean SF-12 PCS score was 44.1±11.8, respectively. Table 2 compares health status scores at 1 year in patients according to quartiles of PM 2.5 exposure. Patients with higher exposure to PM 2.5 had worse health status scores.
In unadjusted analysis (Model 1), there was a significant association of higher PM 2.5 concentration and ozone level with worse generic and disease-specific health status (Figure 1 ). Adjusting for demographics, smoking, SES, and date of enrollment (Model 2) did not attenuate these associations. Even in Model 3, which additionally adjusted for comorbidities associated with air pollution, there remained a significant association with worse SAQ summary score, dyspnea, and SF-12 PCS scores. No significant nonlinearity was found for the effects of either PM 2.5 or ozone on any of the health status outcomes (P>0.1 for all), so all associations are summarized as linear effects. Furthermore, higher PM 2.5 and ozone concentration were significantly associated with worse recovery (ie, change) in health status 1 year after an MI (Figure 2) .
To assess whether ozone levels moderated the association of PM 2.5 and health status, we modified Model 2 to include an interaction between PM 2.5 and ozone. Although there was no significant interaction for disease-specific health status (SAQ summary score) and SF-12 PCS scores, higher ozone levels were associated with worse dyspnea for the same PM 2.5 concentration ( Figure II in the Data Supplement).
Association Between PM 2.5 and Ozone With 5-Year All-Cause Mortality
There was no loss to follow-up in the ascertainment of all-cause mortality at 5 years outcome. Higher quartiles (Q) of PM 2.5 exposure in the year leading up to the MI were associated with lower crude 5-year survival (Q1: 85.2%, Q2: 82.1%, Q3: 76.8%, and Q4: 73.1%; P<0.001). The association with ozone levels, while nominally significant in unadjusted analyses, was weaker (Q1: 79.7%, Q2: 80.7%, Q3: 79.6%, and Q4: 77.1%; P=0.03; Figure III in the Data Supplement). In Cox regression analysis adjusting for patient factors, higher PM 2.5 exposure was associated with greater mortality risk (hazard ratio=1.13 per +1 SD, 95% CI, 1.07-1.20; P<0.001), while ozone level was not (hazard ratio=1.01 per +1 SD, 95% CI, 0.96-1.06; P=0.67). The proportional hazards assumption was satisfied for both parameters (P>0.3), and no evidence of nonlinearity was found (P=0.59).
DISCUSSION
US policy on air pollution standards is in flux. Recent changes to the regulation of air pollution seek to promote fossil fuels and abandon prior efforts to curb greenhouse gas emissions. This has raised concerns about the deleterious health effects of air pollutants, such as PM 2.5 and ozone. 31 In this first analysis of the association of long-term exposure to PM 2.5 and ozone with health status and all-cause mortality after MI, we found small but statistically significant linear associations of higher long-term exposure to ambient air PM 2.5 and ozone with worse disease-specific and generic health status in patients with MI, as well as increased risks of 5-year mortality with higher exposures to PM 2.5 particles.
Previous studies have shown an association of increased long-term exposure to PM 2.5 with higher allcause mortality 11 and increased cardiovascular events. 32 In patients with MI, long-term exposure to PM 2.5 was associated with higher cardiovascular mortality. 33 Although some prior studies did not show an association of ozone with cardiovascular outcomes independent of PM 2.5 exposure, 9 studies using more precise estimates of ozone exposure, independent of PM 2.5 , show ozone to also be associated with cardiovascular mortality. 13 Our study confirms findings from previous studies about the association of higher PM 2.5 exposure with mortality and adds to the evaluation of long-term PM 2.5 and ozone exposure with cardiovascular outcomes by demonstrating that both PM 2.5 and ozone are independently associated with poorer 1-year health status after MI. Moreover, finding similar associations with PM 2.5 and post-MI mortality with previously reported studies (and the increased prevalence of comorbidities associated with air pollution in our study) provide external validity of our novel results about worse health status with higher air pollution levels.
Health status outcomes directly assess the impact of disease on patient's symptoms, function, and QoL. In patients with cardiovascular disease, optimizing health status and disease-specific QoL have been recognized as important goals of treatment. 34 In addition to defining treatment factors that influence health status, it is important to consider other risk factors that may negatively affect patients' health status. Our analysis identifies PM 2.5 and ozone exposure as 2 such factors that negatively affect the long-term health status of patients with cardiovascular disease. The mechanisms underlying the association of ozone and PM 2.5 with poorer health status are likely to be complex. There is abundant pathophysiologic evidence supporting the development and progression of coronary disease with air pollution. Long-term exposure of PM 2.5 has been shown to be associated with oxidative stress 35 endothelial dysfunction 36 and increased propensity to coagulation. 37 These processes are thought to drive the association of exposure to PM 2.5 and development/progression of cardiovascular disease. Additionally, exposure to PM 2.5 is strongly associated with several risk factors for cardiovascular disease, including hypertension, 38 DM, 39 dyslipidemia, 40 CKD, 41 obesity, 42 and breathing disorders. 43 Ozone has also been shown to enhance the toxic effects of PM 2.5 29,44 and could have independent effects contributing to adverse cardiovascular outcomes. 45, 46 This complex interplay and biochemical relationships could underlie the observed associations between these air pollutants with health status and mortality after MI.
The observed effect sizes of greater air pollutant exposure to health status are small, although statistically significant. However, it is important to consider the results of our study in the context of the range of PM 2.5 and ozone exposure throughout the United States and the world. While in our study the range for PM 2.5 was 4.3 to 20.5 µg/m 3 , in the United States the range of average exposure to PM 2.5 is estimated to range from 5 to 50 µg/m 3 . 47 Worldwide, the range is even higher, with levels >100 µg/m 3 in some developing countries. 8 As different metrics for ozone concentration are used worldwide, a global comparison is difficult to make. However, it is generally thought that ozone levels measured by daily average of 8-hour maximum vary considerably worldwide. 17 Given that we found a linear relationship with both health status and mortality (for PM 2.5 ), the true impact of both ozone and PM 2.5 could be even greater in patients exposed to higher concentrations of these air pollutants. The Clean Air Act 48 requires the EPA to set National Ambient Air Quality Standards, and the primary standard for average (per year) concentration of PM 2.5 has been set at 12 µg/m 3 and 0.070 ppm for ozone. 8 We observed a significant impact on mortality and health status at concentrations below these standards.
Our findings should be interpreted in the context of the following potential limitations. This study focused on the impact of ambient air PM 2.5 and ozone exposure on health status and mortality in patients after an MI and the primary exposure metric only focused on daily outdoor concentrations. Patients spend their time in various microenvironments, for example, in their homes, offices, shopping malls, and could also be exposed to secondhand smoke. As there is likely to be a lot of variability in air pollutant concentrations in these different environments, it is possible that the total exposure of each patient to could have been misclassified, which would have biased our findings to the null. However, outdoor PM 2.5 and ozone levels have been shown to be strong proxies for total exposure for an individual patient. 49, 50 A second concern is that although we adjusted extensively for comorbid conditions, there is the possibility of residual confounding in this observational study. For example, we did not adjust for recruitment site, as there was a strong correlation between both PM 2.5 and ozone exposure and recruitment site (intraclass correlation coefficient 79% for both), which is not unexpected. Nevertheless, there is the possibility that site-specific factors could have influenced the results, although the intraclass correlations between health status and site were much smaller (range 3%-6%) than for air pollutant exposure (intraclass correlation coefficient =79%). Importantly, even after adjusting for comorbidities that may be along the causal pathway between air pollution and cardiovascular outcomes, a significant association between PM 2.5 and ozone remained. Finally, many patients were excluded as they had missing 1-year health status data or could not be linked to EPA air quality data, making it possible that our results could have been slightly different if we had complete data for all patients enrolled. However, it seems unlikely that patients with missing data would exhibit a different association between exposure and health status than those with complete data, particularly after adjustment for other factors.
CONCLUSIONS
We found a strong association of high long-term exposure to air pollutants with patients' 1-year health status and 5-year all-cause mortality after MI. These findings suggest that greater air pollution not only increases patients' risks for dying but also worsens their symptoms, function, and QoL. While further studies are needed to determine the mechanism of this increased risk, ongoing debates about the regulation of air pollution should consider the impact of higher exposure to PM 2.5 and ozone on patients' health status.
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